Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

E-test Antimicrobial Susceptibility Testing: Principles, Methods, and Applications

E-test antimicrobial susceptibility testing is a quantitative gradient diffusion method used to determine the minimum inhibitory concentration (MIC) of antimicrobial agents against bacteria and fungi. This technique combines the simplicity of disk diffusion with the quantitative precision of broth dilution, making it a trusted tool in clinical microbiology, pharmaceutical quality control, and antimicrobial resistance surveillance. This article provides a comprehensive technical overview of E-test methodology, sample requirements, testing procedures, and practical applications.

Technical Overview

The E-test (Epsilometer test) is a well-established quantitative antimicrobial susceptibility testing method that determines the minimum inhibitory concentration (MIC) of antimicrobial agents against microorganisms. The technique employs a predefined, stable, and continuous concentration gradient of an antimicrobial agent immobilized on the surface of a plastic strip. When the strip is applied to an agar plate inoculated with a standardized microbial suspension, the antimicrobial diffuses into the agar, creating an elliptical zone of inhibition after incubation.

The MIC value is read directly from the scale printed on the strip at the point where the inhibition ellipse intersects the strip edge. This direct gradient diffusion principle allows the E-test to deliver quantitative MIC results with the operational simplicity of agar-based methods. The technique is applicable to a wide range of fastidious and non-fastidious bacteria, as well as yeasts and filamentous fungi, provided the appropriate culture medium, inoculum density, and incubation conditions are selected.

E-test procedures are typically performed in accordance with internationally recognized standards, including CLSI (Clinical and Laboratory Standards Institute) guidelines such as M07 and M100, EUCAST (European Committee on Antimicrobial Susceptibility Testing) methodology, and the general framework of ISO 20776 for susceptibility testing of infectious agents. Quality control is maintained through the use of reference strains, such as those from the ATCC collection, to verify inoculum preparation, medium performance, and incubation conditions.

Testing Samples

Clinical Bacterial Isolates

Pure cultures isolated from clinical specimens, including blood, urine, respiratory secretions, wound swabs, cerebrospinal fluid, and sterile body fluids, constitute the primary sample type. Isolates must be freshly subcultured on appropriate non-selective agar to ensure viability and metabolic activity consistent with the log-phase growth required for standardized inoculum preparation.

Reference and Quality Control Strains

Standardized reference strains, such as Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 29213, Pseudomonas aeruginosa ATCC 27853, and Candida parapsilosis ATCC 22019, are routinely tested alongside clinical isolates to verify the accuracy and reproducibility of MIC determinations. Acceptable QC ranges are defined by CLSI and EUCAST documents.

Environmental and Pharmaceutical Isolates

Bacterial and fungal isolates recovered from cleanroom environments, water systems, raw materials, finished pharmaceutical products, and medical devices can be evaluated for susceptibility patterns as part of contamination investigations, preservative efficacy support studies, and bioburden characterization programs.

Veterinary and Food-Related Isolates

Pathogenic and indicator organisms isolated from animal health specimens and food production chains, including Salmonella, Campylobacter, and Enterococcus species, may be tested to monitor antimicrobial resistance trends under a One Health framework.

Testing Items

E-test susceptibility determination covers a broad antimicrobial spectrum. Commonly evaluated agents include:

  • Beta-lactam antibiotics: penicillin, ampicillin, oxacillin, cefotaxime, ceftazidime, cefepime, and piperacillin-tazobactam
  • Glycopeptides: vancomycin and teicoplanin, including MIC confirmation for suspected vancomycin-intermediate or resistant Staphylococcus aureus
  • Aminoglycosides: gentamicin, tobramycin, and amikacin
  • Fluoroquinolones: ciprofloxacin, levofloxacin, and moxifloxacin
  • Macrolides and lincosamides: erythromycin, azithromycin, and clindamycin, with D-zone testing support for inducible clindamycin resistance
  • Tetracyclines, sulfonamides, and nitrofurans as clinically indicated
  • Antifungal agents: amphotericin B, fluconazole, voriconazole, posaconazole, and caspofungin for yeast and mold isolates
  • Specialized resistance markers: colistin MIC determination for Gram-negative multidrug-resistant organisms and beta-lactamase inhibitor combinations

Results are reported as MIC values in mg/L (µg/mL) and interpreted as Susceptible (S), Intermediate (I), Susceptible-Dose Dependent (SDD), Resistant (R), or the EUCAST category Susceptible-Increased Exposure (I) according to current clinical breakpoints.

Testing Methods

The E-test procedure follows a standardized workflow designed to ensure reproducible and accurate MIC determination:

  • Inoculum preparation: Colonies from an 18–24 hour pure culture are suspended in sterile saline or broth and adjusted to a turbidity equivalent to a 0.5 McFarland standard (approximately 1–2 × 10⁸ CFU/mL for bacteria; 1–5 × 10⁶ CFU/mL for yeasts).
  • Plate inoculation: The standardized suspension is swabbed uniformly across the entire surface of an appropriate agar medium, such as Mueller-Hinton agar for non-fastidious bacteria, Mueller-Hinton with 5% sheep blood for fastidious organisms, or RPMI 1640 agar with MOPS for fungi.
  • Strip application: Within 15 minutes of inoculation, E-test strips are applied to the dried agar surface using sterile forceps or an applicator, with the concentration scale facing upward. Up to four to six strips may be placed on a standard 90–150 mm plate depending on organism growth characteristics.
  • Incubation: Plates are incubated inverted under organism-specific conditions, typically 35 ± 2°C in ambient air for 16–24 hours for common aerobes, with extended incubation (24–48 hours) or supplemented atmospheres (5% CO₂) required for fastidious bacteria and anaerobes.
  • Reading and interpretation: The MIC is read at the point where the inhibition ellipse intersects the strip. When growth extends above or below the strip intersection, the higher value is recorded. MIC values are then interpreted against current CLSI or EUCAST breakpoints to assign a susceptibility category.
  • Quality control: Each testing run includes reference strains with defined MIC ranges, and lot verification of media and strips is performed and documented in accordance with laboratory quality management systems aligned with ISO 15189 or ISO/IEC 17025 requirements.

Key technical considerations include proper strip storage at −20°C to 8°C, allowance of strips to reach room temperature before opening the container, avoidance of moisture on the agar surface, and adherence to the maximum time window between inoculation and strip application to prevent false-elevated MIC values.

Applications

E-test antimicrobial susceptibility testing serves diverse purposes across clinical, industrial, and research settings:

  • Clinical microbiology: Providing quantitative MIC data to guide targeted antimicrobial therapy, particularly for serious infections such as bacteremia, endocarditis, osteomyelitis, and meningitis where precise dosing depends on MIC magnitude.
  • Resistance mechanism confirmation: Confirming borderline or unexpected disk diffusion results, detecting methicillin resistance in staphylococci, vancomycin resistance in enterococci, and penicillin resistance in pneumococci and viridans group streptococci.
  • Antimicrobial resistance surveillance: Generating high-resolution MIC distributions for national and international resistance monitoring programs and epidemiological studies.
  • Pharmaceutical microbiology: Characterizing the susceptibility profiles of environmental isolates and objectionable organisms identified during contamination investigations in GMP-regulated facilities.
  • Antifungal stewardship: Supporting therapeutic decision-making for candidemia and invasive mold infections through standardized MIC determination against major antifungal classes.
  • Research and development: Evaluating novel antimicrobial candidates, studying resistance emergence, and validating susceptibility test methods in academic and industrial research laboratories.

FAQ

What is the difference between E-test and disk diffusion testing?

Disk diffusion provides only a qualitative or category result (susceptible, intermediate, or resistant) based on the zone diameter around a fixed antibiotic concentration. The E-test, by contrast, generates a quantitative MIC value using a continuous concentration gradient, offering greater precision for therapeutic dosing decisions and for confirming resistance mechanisms that disk diffusion may not reliably detect.

How accurate is the E-test compared with reference broth microdilution?

Studies consistently demonstrate high categorical agreement between E-test and broth microdilution, typically exceeding 90–95% for most organism-antimicrobial combinations when performed with appropriate media and incubation conditions. Minor discrepancies may occur near breakpoint concentrations, which is why standardized QC procedures and, when clinically indicated, confirmatory testing are recommended.

What is the typical turnaround time for E-test results?

For rapidly growing aerobic bacteria, results are generally available after 16–24 hours of incubation. Fastidious organisms, anaerobes, and fungi may require 24–72 hours depending on the species and growth conditions specified by CLSI or EUCAST guidance.

Can the E-test be used for anaerobic bacteria and fungi?

Yes. When appropriate media, inoculum densities, and incubation atmospheres are selected according to established standards, the E-test is suitable for anaerobes, yeasts such as Candida species, and certain filamentous fungi, delivering MIC values that support antifungal and anti-anaerobic therapy decisions.

How should unexpected or borderline MIC results be handled?

Borderline or discordant results should trigger repeat testing with fresh subcultures, verification of inoculum density and medium performance using QC reference strains, and consideration of confirmatory molecular or phenotypic methods. Documented review by qualified microbiologists ensures the final susceptibility report is clinically reliable.

What quality standards govern E-test susceptibility testing?

E-test procedures are aligned with CLSI documents such as M07, M27, M44, and M100, EUCAST disk diffusion and MIC methodology, and the general framework of ISO 20776-1. Laboratories performing this testing typically operate under quality management systems conforming to ISO 15189 or ISO/IEC 17025, with accredited third-party laboratories providing independent testing services where external verification is required.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing